GEA builds process plant for the production of immunoglobulin for CSL Behring in Bern

2020-08-14
"PROTINUS" (lat. forward, further") is the name of the project with which the biopharmaceutical company CSL Behring will significantly increase the production capacity of immunoglobulin at its site. GEA received the order for the process plant, the heart of the facility.
 
To view the complete content, please log in.
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
Midez MBT